{"schema_version":"secwatch.filing_event.v1","accession":"0001756655-25-000013","form_type":"8-K","ticker":"ARDT","cik":"0001756655","company_name":"Ardent Health, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.887108+00:00","generated_at":"2026-05-17T20:52:17.432654+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Ardent Health Q2 revenue up 12% to $1.65B; Adj EBITDA +39% to $170M; reaffirms FY25 guidance","bullets":["Net income $73M ($0.52 diluted EPS) vs $43M ($0.34) prior year; adjusted EBITDA $170M.","Total revenue $1.645B (+11.9% YoY) driven by 1.6% adjusted admission growth and 10.2% revenue per adjusted admission.","Admissions +6.6% YoY; inpatient surgeries +9.2% but outpatient surgeries -3.8%.","Lease-adjusted net leverage ratio improved to 2.7x from 3.0x in Q1; available liquidity $835M.","Reaffirms FY25 guidance: revenue $6.2-6.45B, Adj EBITDA $575-615M, diluted EPS $1.73-2.01."],"urls":{"canonical":"https://secwatch.observer/filing/0001756655-25-000013","json":"https://secwatch.observer/filing/0001756655-25-000013.json","markdown":"https://secwatch.observer/filing/0001756655-25-000013.md","text":"https://secwatch.observer/filing/0001756655-25-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756655/000175665525000013/0001756655-25-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756655/000175665525000013/ardt-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:52:17.432654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}